Signification of Decoy Receptor 3 (DcR3) and External-Signal Regulated Kinase 1/2 (ERK1/2) in Gastric Cancer Patients Full Text
BMC Immunology, 06/14/2012
Yang D et al. – The results suggest that DcR3 and ERK1/2 play a vital role in gastric cancer formation and development, they could be a new mark to indicate the efficiency of gastric cancer treatment.



